Author:
Tsai Hui-Jen,Jiang Shih Sheng,Hung Wen-Chun,Borthakur Gautam,Lin Sheng-Fung,Pemmaraju Naveen,Jabbour Elias,Bomalaski John S.,Chen Ya-Ping,Hsiao Hui-Hua,Wang Ming-Chung,Kuo Ching-Yuan,Chang Hung,Yeh Su-Peng,Cortes Jorge,Chen Li-Tzong,Chen Tsai-Yun
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Döhner, H. et al. Acute myeloid leukemia. N Engl J Med 373, 1136–1152 (2015).
2. Health Promotion Administration, Ministry of Health and Welfare, Taiwan Health Promotion Administration Annual Report. Available from:
http://www.hpa.gov.tw/EngPages/List.aspx?nodeid=1072
. Date of access: 10/05/2017 (2016).
3. Hengeveld, M. et al. Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Malignedell ‘Adulto (GIMEMA) Leukemia Cooperative Groups. Ann Hematol 91, 825–835 (2012).
4. Jehn, U. et al. Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial. Leukemia 20, 1723–1730 (2006).
5. Patel, J. P. et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 366, 1079–1089 (2012).
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献